-
The Impact of Adherence on the Value Assessment of Cardiovascular Interventions: A Systematic Literature Review of Economic Evaluations
Sep 9, 2025, 16:22 PM -
Potential Public Health Benefits of Recombinant Influenza Vaccines in Older Adults in England and Wales
Sep 9, 2025, 16:22 PM -
Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body: Improvements in Patient-Reported Outcomes and Quality of Life
Sep 9, 2025, 16:22 PM -
Navigating Joint Clinical Assessment in Europe: Strategic Roadmap and Recommendations for Health Technology Developers
Sep 9, 2025, 16:22 PM -
Development of a Multidimensional HTA Evaluation for the Introduction of Clesrovimab in Pediatric RSV Prevention: An Integrated Methodological Approach
Sep 9, 2025, 16:22 PM -
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD) in India: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Investigating the Patient-Relevance of Achieving Blood Phe Thresholds in PKU: Results From an Analysis of the OPAL Study
Sep 9, 2025, 16:22 PM -
Impact of Pharmacist-Led Interventions on Health-Related Quality of Life in Diabetic Patients: Assessment Using EQ-5D Domains and Visual Analog Scale
Sep 9, 2025, 16:22 PM -
Exploring Quality of Life in Duchenne Muscular Dystrophy: Insights From Qualitative Patient and Caregiver Interviews
Sep 9, 2025, 16:22 PM -
Describing the Burden of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) on Patients and Their Caregivers: A Real-World Survey in Europe, the United States, and Japan
Sep 9, 2025, 16:22 PM -
Real-World Characterization of Urticaria Subtypes in Brazil: A TriNetX-Based Analysis of Demographics, Comorbidities, Treatments, and Laboratory Markers
Sep 9, 2025, 16:22 PM -
Cost Implications of Declining MMR Coverage in England: Modeling NHS Burden and the Value of Catch-Up Vaccination
Sep 9, 2025, 16:22 PM -
Patient-Relevant Benefits From Ixekizumab Treatment in Patients With Psoriasis: Data From the German National Psoriasis Registry PsoBest
Sep 9, 2025, 16:22 PM -
Orphan Drug Approvals in the US and Europe: A 2-Year Comparison
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Costs by Glycemic Control in People With Type 2 Diabetes: An Observational Population-based Register Study in Sweden
Sep 9, 2025, 16:22 PM -
Evaluating an Augmented Reality Software for Mechanical Thrombectomy Using the Lean Assessment Process Methodology: Identifying Clinical Needs, Stakeholder Acceptance, and Adoption Barriers in the NHS
Sep 9, 2025, 16:22 PM -
Advocating From the Margins: How Patient Input Aligns With Broader Evidence Tolerance in HTA Within Oncology
Sep 9, 2025, 16:22 PM -
Considerations for Modeling Caregiver Spillover Within Economic Evaluations for Neurological Disorders: Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), and Multiple Sclerosis (MS)
Sep 9, 2025, 16:22 PM -
Estimated Long-Term Healthcare Cost Savings From EVP Use in the UK
Sep 9, 2025, 16:22 PM -
Economic Impact of Faricimab in Neovascular Age-Related Macular Degeneration Management in France
Sep 9, 2025, 16:22 PM
